INFEX Therapeutics
David Orr is a highly experienced scientist with a strong background in synthetic organic chemistry. With a Doctor of Philosophy (PhD) in Synthetic Organic and Computational Chemistry, David has worked at various companies including INFEX Therapeutics, Apex Molecular Ltd, Redx Pharma, and GSK. Throughout their career, David has contributed to the synthesis of novel compounds for drug discovery, particularly focusing on anti-bacterial compounds and heteroarenes. David has also received awards for their contributions and achievements in the field.
This person is not in any teams
INFEX Therapeutics
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.